These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 959848)

  • 1. Hyaluronidase-induced reductions in myocardial infarct size.
    Maclean D; Fishbein MC; Maroko PR; Braunwald E
    Science; 1976 Oct; 194(4261):199-200. PubMed ID: 959848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pharmacological intervention on infarct size following induced myocardial infarction in rats.
    Barletta MA; Staab R; Lau Cam C; Lynch VD
    J Pharm Sci; 1978 Nov; 67(11):1643-5. PubMed ID: 712614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term preservation of ischemic myocardium after experimental coronary artery occlusion.
    Maclean D; Fishbein MC; Braunwald E; Maroko PR
    J Clin Invest; 1978 Mar; 61(3):541-51. PubMed ID: 641137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of infarct size following coronary occlusion.
    Braunwald E; Maroko PR; Libby P
    Circ Res; 1974 Sep; 35 Suppl 3():192-201. PubMed ID: 4606996
    [No Abstract]   [Full Text] [Related]  

  • 5. A method for demonstrating the efficacy of interventions designed to limit infarct size following coronary occlusion: beneficial effect of hyaluronidase.
    Riberio LG; Hillis LD; Louie EK; Davis MA; Maroko PR; Braunwald E
    Cardiovasc Res; 1978 Jun; 12(6):334-40. PubMed ID: 698985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion.
    Ginks WR; Sybers HD; Maroko PR; Covell JW; Sobel BE; Ross J
    J Clin Invest; 1972 Oct; 51(10):2717-23. PubMed ID: 5056664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a highly purified hyaluronidase preparation on experimental myocardial infarction in the rat.
    Nilsson JE; Sjögren C; Säwe U
    Acta Med Scand; 1984; 216(2):209-13. PubMed ID: 6496178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of experimental myocardial infarct size by corticosteroid administration.
    Libby P; Maroko PR; Bloor CM; Sobel BE; Braunwald E
    J Clin Invest; 1973 Mar; 52(3):599-607. PubMed ID: 4685084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptokinase alters myocardial creatine kinase depletion after ischaemia and reperfusion in rabbits.
    Mickelson JK; Carlson CJ; Margaretten W; Rapaport E
    Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):637-46. PubMed ID: 3802580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.
    Shell WE; Kjekshus JK; Sobel BE
    J Clin Invest; 1971 Dec; 50(12):2614-25. PubMed ID: 5129313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS).
    Roberts R; Braunwald E; Muller JE; Croft C; Gold HK; Hartwell TD; Jaffe AS; Mullin SM; Parker C; Passamani ER
    Br Heart J; 1988 Oct; 60(4):290-8. PubMed ID: 3056476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation.
    Cairns JA; Holder DA; Tanser P; Missirlis E
    Circulation; 1982 Apr; 65(4):764-71. PubMed ID: 7060255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hyaluronidase and hydrocortisone on myocardial necrosis after coronary occlusion.
    Braunwald E; Maroko PR
    Am J Cardiol; 1976 Mar; 37(4):550-6. PubMed ID: 1258792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of hyaluronidase and hydrocortisone in the reduction of myocardial infarct size following coronary occlusion. Experimental and clinical observations.
    Braunwald E; Maroko PR
    Acta Med Scand Suppl; 1976; 587():169-76. PubMed ID: 1062125
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion.
    Maroko PR; Libby P; Bloor CM; Sobel BE; Braunwald E
    Circulation; 1972 Sep; 46(3):430-7. PubMed ID: 5071733
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electron-microscopic study of changes in the myocyte ultrastructure under the effect of hyaluronidase in experimental myocardial infarct].
    Afonskaia NI; Sharov VG; Nikolaeva LF
    Kardiologiia; 1977 Aug; 17(8):114-8. PubMed ID: 926553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs.
    Hillis LD; Fishbein MC; Braunwald E; Maroko PR
    Circ Res; 1977 Jul; 41(1):26-31. PubMed ID: 862139
    [No Abstract]   [Full Text] [Related]  

  • 18. Active drainage of cardiac lymph in relation to reduction in size of myocardial infarction: an experimental study.
    Taira A; Uehara K; Fukuda S; Takenada K; Koga M
    Angiology; 1990 Dec; 41(12):1029-36. PubMed ID: 2278398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hyaluronidase on experimental cerebral infarct size and mortality.
    Yasuda T; Ribeiro LG; Maroko PR
    Lab Invest; 1982 Apr; 46(4):400-4. PubMed ID: 7070054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of oxyfedrine on myocardial infarct size following coronary artery occlusion in rats (author's transl)].
    Chiariello M; Brevetti G; Petillo F; Ferro G; Giasi M; Condorelli M
    G Ital Cardiol; 1981; 11(3):373-9. PubMed ID: 6116640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.